A phase 2, randomized, investigator and participant blinded, placebo-controlled, parallel-group study to investigate the safety, tolerability, and…
BackgroundIn response to the growing concern surrounding childhood obesity, we are thrilled to introduce a Phase 1 FDA-regulated clinical trial aimed…
Background
Smith-Magenis Syndrome (SMS) is a genetic syndrome caused by mutations in the RAI1 gene or deletions of the 17p11.2 chromosome.…
Studying the role of nutrition in infant and toddler health is challenging. Young children cannot tell us what they eat. Many children eat meals away…
IgA is a defense protein that lines the gut and can be measured in blood. IgA changes how much and what types of bacteria are in the gut. The amount…
Long Term Extension Trial Of Setmelanotide (RM-493) For Patients Who Have Completed A Trial Of Setmelanotide For The Treatment Of Obesity Associated…
M16-067: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Induction Study to Evaluate the Efficacy and Safety of Risankizumab in Subjects…
RPC-3201: Induction Study #1 - A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Oral Ozanimod as Induction Therapy for…
What is the purpose of this study?
This is the long term extension of Gilead 95. The goals of The Gilead 96 study are in line with that of Gilead 95…
The University of Kentucky will analyze serum from IBD and normal patients for peripheral blood exosome lipid composition using an ultrahigh…